| Restatement | 2. Restatement As described in Note 1, the Company has restated the unaudited condensed consolidated Statements of Operations and Comprehensive Loss for the three month period ended March 31, 2021 and three and six months periods ended June 30, 2021 to reflect the Expense Allocation Adjustments. Audited Consolidated Financial Statements (As Restated) As described in Note 1, the Company has restated the Consolidated Balance Sheets, Consolidated Statements of Operations and Comprehensive Loss and Consolidated Statement of Cash flows as of and for the year ended December 31, 2020. The Company’s decision to restate the consolidated financial statements is based on the Company’s conclusion that its non-current derivative liabilities relating to the CLNs were incorrectly valued leading to an understatement of $4.8 million. There was also an understatement of the Advanced Subscription Agreements of $22.0 thousand; understatement of Additional paid in capital of $0.9 million; overstatement of Accumulated other comprehensive income of $0.3 million; and a corresponding understatement to Net loss of $5.4 million recognized during the year ended December 31, 2020. Restated unaudited quarterly financial data for the interim periods in 2021 is also presented below. The following tables set forth a summary of where the restatement adjustments had an effect on Legacy Wejo’s consolidated financial statements as of December 31, 2020: Consolidated Balance Sheets Year Ended December 31, 2020 (in thousands) Reported Valuation Adjustments (1) As Restated Assets Current assets: Cash $ 14,421 $ — $ 14,421 Accounts receivable, net 688 — 688 Prepaid expenses and other current assets 6,053 — 6,053 Total current assets 21,162 — 21,162 Property and equipment, net 320 — 320 Intangible assets, net 10,946 — 10,946 Total assets $ 32,428 $ — $ 32,428 Liabilities and Shareholders’ Deficit Current liabilities: Accounts payable $ 4,890 $ — $ 4,890 Accrued expenses and other current liabilities 9,891 — 9,891 Advanced Subscription Agreement 8,098 22 8,120 Debt to related parties 10,129 — 10,129 Total current liabilities 33,008 22 33,030 Non-current liabilities: Convertible loan notes 6,130 — 6,130 Derivative liability 34,982 4,798 39,780 Other non-current liabilities 84 — 84 Total liabilities 74,204 4,820 79,024 Commitments and contingencies Shareholders’ deficit: Ordinary Shares 87 — 87 B Ordinary Shares 67 — 67 Additional paid in capital 104,799 918 105,717 Accumulated deficit (146,770) (5,403) (152,173) Accumulated other comprehensive income (loss) 41 (335) (294) Total shareholders’ deficit (41,776) (4,820) (46,596) Total liabilities and shareholders’ deficit $ 32,428 $ — $ 32,428 (1) The "Valuation Adjustments" pertain to the restatement in relation to the misinterpretation of certain conversion terms of the CLN agreement and using the wrong output from the valuation report as described in Note 1 and Note 2. Consolidated Statements of Operations and Comprehensive Loss Year Ended December 31, 2020 (in thousands, except share and per share amounts) Reported Valuation Adjustments (1) As Restated Revenue, net $ 1,336 $ — $ 1,336 Costs and operating expenses: Cost of revenue (exclusive of depreciation and amortization shown separately below) 1,688 — 1,688 Technology and development 7,683 — 7,683 Sales and marketing 7,039 — 7,039 General and administrative 10,173 — 10,173 Depreciation and amortization 4,077 — 4,077 Total costs and operating expenses 30,660 — 30,660 Loss from operations (29,324) — (29,324) Loss on issuance of convertible loan notes (13,112) (2,924) (16,036) Loss on fair value of derivative liability (8,724) (2,409) (11,133) Loss on fair value of Advanced Subscription Agreements (1,808) (70) (1,878) Interest expense (2,594) — (2,594) Other income, net 687 — 687 Net loss (54,875) (5,403) (60,278) Other comprehensive loss: Foreign currency exchange translation adjustment (2,220) (335) (2,555) Total comprehensive loss $ (57,095) $ (5,738) $ (62,833) Net loss per common share - basic and diluted $ (1.51) $ (0.15) $ (1.66) Weighted-average basic and diluted common shares 36,285,113 — 36,285,113 (1) The “Valuation Adjustments” pertain to the restatement in relation to the misinterpretation of certain conversion terms of the CLN agreement and using the wrong output from the valuation report as described in Note 1 and Note 2. Consolidated Statements of Cash Flows Year Ended December 31, 2020 (in thousands) Reported Valuation Adjustments (1) As Restated Operating activities Net loss $ (54,875) $ (5,403) $ (60,278) Adjustments to reconcile net loss to net cash used in operating activities: Non-cash interest expense 1,078 — 1,078 Loss on issuance of convertible loans 13,112 2,924 16,036 Loss on disposal of property and equipment 58 — 58 Depreciation and amortization 4,077 — 4,077 Non-cash loss on foreign currency remeasurement 338 — 338 Loss on fair value of Advanced Subscription Agreements 1,808 70 1,878 Loss on fair value of derivative liability 8,724 2,409 11,133 Changes in operating assets and liabilities: Accounts receivable (400) — (400) Prepaid expenses and other current assets (90) — (90) Accounts payable 2,647 — 2,647 Accrued expenses and other liabilities 2,023 — 2,023 Net cash used in operating activities (21,500) — (21,500) Investing activities Purchase of property and equipment (55) — (55) Development of internal software (1,810) — (1,810) Net cash used in investing activities (1,865) — (1,865) Financing activities Proceeds from the issuance of ordinary shares, net of issuance costs 1,004 — 1,004 Proceeds from issuance of advance subscriptions, net of issuance costs 348 — 348 Proceeds from issuance of convertible loans 25,222 — 25,222 Payment of issuance costs of convertible loans (852) — (852) Proceeds from other loan 84 — 84 Proceeds from issuance of related party debt 9,862 — 9,862 Net cash provided by financing activities 35,668 — 35,668 Effect of exchange rate changes on cash 823 — 823 Net increase in cash 13,126 — 13,126 Cash at beginning of period 1,295 1,295 Cash at end of period $ 14,421 $ — $ 14,421 Non-cash financing activities Advanced subscription agreements converted into common shares $ 1,396 $ 53 $ 1,449 Supplemental cash flow information Interest paid $ 529 $ — $ 529 (1) The “Valuation Adjustments” pertain to the restatement in relation to the misinterpretation of certain conversion terms of the CLN agreement and using the wrong output from the valuation report as described in Note 1 and Note 2. Interim Financial Information (As Restated) Restatement information related to unaudited condensed consolidated financial statements The following tables present the unaudited condensed consolidated financial statements for the quarters in 2021 and summarize where the restatement adjustments had an effect on the Company's unaudited condensed consolidated financial statements: Unaudited Condensed Consolidated Balance Sheets March 31, 2021 (in thousands) As Reported Valuation Adjustments (1) As Restated Assets Current assets: Cash $ 20,467 $ — $ 20,467 Accounts receivable, net 636 — 636 Prepaid expenses and other current assets 5,088 — 5,088 Total current assets 26,191 — 26,191 Property and equipment, net 387 — 387 Intangible assets, net 10,407 — 10,407 Total assets $ 36,985 — $ 36,985 Liabilities and Shareholders’ Deficit Current liabilities: Accounts payable $ 6,355 $ — $ 6,355 Accrued expenses and other current liabilities 7,894 — 7,894 Advanced Subscription Agreements 9,227 247 9,474 Debt to related parties 10,141 — 10,141 Total current liabilities 33,617 247 33,864 Non-current liabilities: Convertible loan notes 6,937 — 6,937 Derivative liability 101,003 25,060 126,063 Total liabilities 141,557 25,307 166,864 Commitments and contingencies Shareholders’ deficit: Ordinary shares 87 — 87 B Ordinary shares 67 — 67 Additional paid in capital 121,760 3,602 125,362 Accumulated deficit (226,203) (28,327) (254,530) Accumulated other comprehensive loss (283) (582) (865) Total shareholders’ deficit (104,572) (25,307) (129,879) Total liabilities and shareholders’ deficit $ 36,985 $ — $ 36,985 (1) The “Valuation Adjustments” pertain to the restatement in relation to the misinterpretation of certain conversion terms of the CLN agreement and using the wrong output from the valuation report as described in Note 1 and Note 2. June 30, 2021 (in thousands) As Reported Valuation Adjustments (1) As Restated Assets Current assets: Cash $ 15,275 $ — $ 15,275 Accounts receivable, net 609 — 609 Prepaid expenses and other current assets 10,976 — 10,976 Total current assets 26,860 — 26,860 Property and equipment, net 485 — 485 Intangible assets, net 10,297 — 10,297 Total assets $ 37,642 — $ 37,642 Liabilities and Shareholders’ Deficit Current liabilities: Accounts payable $ 4,808 $ — $ 4,808 Accrued expenses and other current liabilities 14,754 — 14,754 Advanced Subscription Agreement 14,914 (2,100) 12,814 Debt to related parties 177 — 177 Total current liabilities 34,653 (2,100) 32,553 Non-current liabilities: Convertible loan notes 7,894 — 7,894 Derivative liability 128,357 (30,549) 97,808 Long term debt, net of unamortized debt discount and debt issuance costs 17,113 — 17,113 Total liabilities 188,017 (32,649) 155,368 Commitments and contingencies Shareholders’ deficit: Ordinary shares 87 — 87 B Ordinary shares 67 — 67 Additional paid in capital 132,023 4,983 137,006 Accumulated deficit (283,028) 28,752 (254,276) Accumulated other comprehensive income (loss) 476 (1,086) (610) Total shareholders’ deficit (150,375) 32,649 (117,726) Total liabilities and shareholders’ deficit $ 37,642 $ — $ 37,642 (1) The “Valuation Adjustments” pertain to the restatement in relation to the misinterpretation of certain conversion terms of the CLN agreement and using the wrong output from the valuation report as described in Note 1 and Note 2. September 30, 2021 (in thousands) As Reported Valuation Adjustments (1) As Restated Assets Current assets: Cash $ 8,611 $ — $ 8,611 Accounts receivable, net 930 — 930 Prepaid expenses and other current assets 12,577 — 12,577 Total current assets 22,118 — 22,118 Property and equipment, net 603 — 603 Intangible assets, net 9,917 — 9,917 Total assets $ 32,638 $ — $ 32,638 Liabilities and Shareholders’ Deficit Current liabilities: Accounts payable $ 7,282 $ — $ 7,282 Accrued expenses and other current liabilities 20,957 — 20,957 Debt to related parties 34 — 34 Total current liabilities 28,273 — 28,273 Non-current liabilities: Convertible loan notes 8,809 — 8,809 Derivative liability 126,927 (34,665) 92,262 Long term debt, net of unamortized debt discount and debt issuance costs 26,313 — 26,313 Total liabilities 190,322 (34,665) 155,657 Commitments and contingencies Shareholders’ deficit: Ordinary shares 89 — 89 B Ordinary shares 70 — 70 Additional paid in capital 146,768 2,990 149,758 Accumulated deficit (308,678) 33,531 (275,147) Accumulated other comprehensive income (loss) 4,067 (1,856) 2,211 Total shareholders’ deficit (157,684) 34,665 (123,019) Total liabilities and shareholders’ deficit $ 32,638 $ — $ 32,638 (1) The “Valuation Adjustments” pertain to the restatement in relation to the misinterpretation of certain conversion terms of the CLN agreement and using the wrong output from the valuation report as described in Note 1 and Note 2. Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss Unaudited Three Months Ended March 31, 2021 (in thousands, except share and per share amounts) As Reported Expense Allocation Adjustments (1) Valuation Adjustments (2) As Restated Revenue, net $ 305 $ — $ — $ 305 Costs and operating expenses: Cost of revenue (exclusive of depreciation and amortization shown separately below) 799 (446) — 353 Technology and development (1) 2,618 (136) — 2,482 Sales and marketing (1) 2,567 (113) — 2,454 General and administrative (1) 2,237 695 — 2,932 Depreciation and amortization 1,025 — — 1,025 Total costs and operating expenses 9,246 — — 9,246 Loss from operations (8,941) — — (8,941) Loss on issuance of convertible loan notes (27,343) — (5,958) (33,301) Loss on fair value of derivative liability (40,160) — (16,742) (56,902) Loss on fair value of Advanced Subscription Agreements (1,048) — (224) (1,272) Interest expense (1,862) — — (1,862) Other expense, net (79) — — (79) Net loss (79,433) — (22,924) (102,357) Other comprehensive loss: Foreign currency exchange translation adjustment (324) — (247) (571) Total comprehensive loss $ (79,757) $ — $ (23,171) $ (102,928) Net loss per ordinary share – basic and diluted $ (2.18) $ — $ (0.63) $ (2.81) Weighted-average basic and diluted ordinary shares 36,463,696 $ — $ — 36,463,696 (1) The “Expense Allocation Adjustments” relate to the allocation error of certain employee, post-retirement and other related expenses and recognizes the impact to the period presented of the restatement disclosed in the Company's Form 10-Q/A and described in Note 1 and Note 2. This adjustment is not related to the “Valuation Adjustments” described below. (2) The "Valuation Adjustments" pertain to the restatement in relation to the misinterpretation of certain conversion terms of the CLN agreement and using the wrong output from the valuation report as described in Note 1 and Note 2. Unaudited Three Months Ended June 30, 2021 (in thousands, except share and per share amounts) As Reported Expense Allocation Adjustments (1) Valuation Adjustments (2) As Restated Revenue, net $ 542 $ — $ 542 Costs and operating expenses: Cost of revenue (exclusive of depreciation and amortization shown separately below) 1,543 (920) — 623 Technology and development 3,877 25 — 3,902 Sales and marketing 3,572 (42) — 3,530 General and administrative 5,712 937 — 6,649 Depreciation and amortization 1,130 — — 1,130 Total costs and operating expenses 15,834 — — 15,834 Loss from operations (15,292) — — (15,292) Loss on issuance of convertible loan notes (16,899) — (3,767) (20,666) Gain (loss) on fair value of derivative liability (16,456) — 58,489 42,033 Loss on fair value of Advanced Subscription Agreements (5,717) — 2,357 (3,360) Interest expense (2,455) — — (2,455) Other expense, net (6) — — (6) Net (loss) income (56,825) — 57,079 254 Other comprehensive loss: Foreign currency exchange translation adjustment 759 — (504) 255 Total comprehensive (loss) income $ (56,066) $ — $ 56,575 $ 509 Net (loss) income per ordinary share - Basic $ (1.56) $ — $ 1.57 $ 0.01 Net (loss) income per ordinary share - Diluted $ (1.56) $ — $ 1.57 $ 0.01 Weighted-average basic ordinary shares 36,463,696 — — 36,463,696 Weighted-average diluted ordinary shares (3) 36,463,696 — 2,880,163 39,343,859 (1) The “Expense Allocation Adjustments” relate to the allocation error of certain employee, post-retirement and other related expenses and recognizes the impact to the period presented of the restatement disclosed in the Company's Form 10-Q/A and described in Note 1 and Note 2. This adjustment is not related to the “Valuation Adjustments” described below. (2) The “Valuation Adjustments” pertain to the restatement in relation to the misinterpretation of certain conversion terms of the CLN agreement and using the wrong output from the valuation report as described in Note 1 and Note 2. (3) The adjustment represents 1,826,890 warrants and 1,053,273 ASAs to purchase ordinary shares of Legacy Wejo which became dilutive securities as a result of the restatement. Unaudited Six Months Ended June 30, 2021 (in thousands, except share and per share amounts) As Reported Expense Allocation Adjustments (1) Valuation Adjustments (2) As Restated Revenue, net $ 847 $ — $ — $ 847 Costs and operating expenses: Cost of revenue (exclusive of depreciation and amortization shown separately below) 2,342 (1,366) — 976 Technology and development 6,495 (111) — 6,384 Sales and marketing 6,139 (155) — 5,984 General and administrative 7,949 1,632 — 9,581 Depreciation and amortization 2,155 — — 2,155 Total costs and operating expenses 25,080 — — 25,080 Loss from operations (24,233) — — (24,233) Loss on issuance of convertible loan notes (44,242) — (9,725) (53,967) Gain (loss) on fair value of derivative liability (56,616) — 41,747 (14,869) Loss on fair value of Advanced Subscription Agreements (6,765) — 2,133 (4,632) Interest expense (4,317) — — (4,317) Other expense, net (85) — — (85) Net (loss) income (136,258) — 34,155 (102,103) Other comprehensive loss: Foreign currency exchange translation adjustment 435 — (751) (316) Total comprehensive (loss) income $ (135,823) $ — $ 33,404 $ (102,419) Net (loss) income per ordinary share - Basic $ (3.74) $ — $ 0.94 $ (2.80) Net (loss) income per ordinary share - Diluted $ (3.74) $ — $ 0.94 $ (2.80) Weighted-average basic ordinary shares 36,463,696 — — 36,463,696 Weighted-average diluted ordinary shares 36,463,696 — — 36,463,696 (1) - The “Expense Allocation Adjustments” relate to the allocation error of certain employee, post-retirement and other related expenses and recognizes the impact to the period presented of the restatement disclosed in the Company's Form 10-Q/A and described in Note 1 and Note 2. This adjustment is not related to the “Valuation Adjustments” described below. (2) The “Valuation Adjustments” pertain to the restatement in relation to the misinterpretation of certain conversion terms of the CLN agreement and using the wrong output from the valuation report as described in Note 1 and Note 2. Unaudited Three Months Ended Unaudited Nine Months Ended September 30, 2021 September 30, 2021 (in thousands, except share and per share amounts) As Reported Valuation Adjustments 1 As Restated As Reported Valuation Adjustments 1 As Restated Revenue, net $ 351 $ — $ 351 $ 1,198 $ — $ 1,198 Costs and operating expenses: Cost of revenue (exclusive of depreciation and amortization shown separately below) 888 — 888 1,864 — 1,864 Technology and development 7,691 — 7,691 14,075 — 14,075 Sales and marketing 4,963 — 4,963 10,947 — 10,947 General and administrative 6,665 — 6,665 16,246 — 16,246 Depreciation and amortization 1,108 — 1,108 3,263 — 3,263 Total costs and operating expenses 21,315 — 21,315 46,395 — 46,395 Loss from operations (20,964) — (20,964) (45,197) — (45,197) Loss on issuance of convertible loan notes — — — (44,242) (9,725) (53,967) Gain (Loss) on fair value of derivative liability (1,637) 4,905 3,268 (58,253) 46,652 (11,601) Gain (Loss) on fair value of Advanced Subscription Agreements 288 (126) 162 (6,477) 2,007 (4,470) Interest expense (2,954) — (2,954) (7,271) — (7,271) Other expense, net (383) — (383) (468) — (468) Net loss (25,650) 4,779 (20,871) (161,908) 38,934 (122,974) Other comprehensive loss: Foreign currency exchange translation adjustment 3,591 (770) 2,821 4,026 (1,521) 2,505 Total comprehensive loss $ (22,059) $ 4,009 $ (18,050) $ (157,882) $ 37,413 $ (120,469) Net loss per ordinary share – basic and diluted $ (0.69) $ 0.13 $ (0.56) $ (4.41) $ 1.06 $ (3.35) Weighted-average basic and diluted ordinary shares 37,162,062 — 37,162,062 36,699,038 — 36,699,038 (1) The “Valuation Adjustments” pertain to the restatement in relation to the misinterpretation of certain conversion terms of the CLN agreement and using the wrong output from the valuation report as described in Note 1 and Note 2. Unaudited Condensed Consolidated Statements of Cash Flows Three Months Ended March 31, 2021 (in thousands) As Reported Valuation Adjustments (1) As Restated Operating activities Net loss $ (79,433) $ (22,924) $ (102,357) Non-cash interest expense 801 — 801 Loss on issuance of convertible loans 27,343 5,958 33,301 Gain on disposal of property and equipment — — — Depreciation and amortization 1,025 — 1,025 Non-cash gain on foreign currency remeasurement (80) — (80) Loss on fair value of Advanced Subscription Agreements 1,048 224 1,272 Loss on fair value of derivative liability 40,160 16,742 56,902 Changes in operating assets and liabilities: Accounts receivable 52 — 52 Prepaid expenses and other current assets 3,154 — 3,154 Accounts payable 1,442 — 1,442 Accrued expenses and other liabilities (4,119) — (4,119) Net cash used in operating activities (8,607) — (8,607) Investing activities Purchase of property and equipment (126) — (126) Development of internal software (316) — (316) Net cash used in investing activities (442) — (442) Financing activities Proceeds from issuance of convertible loans 16,115 16,115 Payment of issuance cost of convertible loans (998) (998) Repayment of other loan (84) — (84) Proceeds from issuance of related party debt 17 — 17 Payment of deferred financing costs (100) — (100) Net cash provided by financing activities 14,950 — 14,950 Effect of exchange rate changes on cash 145 — 145 Net increase in cash 6,046 — 6,046 Cash at the beginning of period 14,421 — 14,421 Cash at the end of the period $ 20,467 $ — $ 20,467 Supplemental disclosure of non-cash financing activities Deferred offering costs included in accounts payable and accrued expenses $ 2,070 $ — $ 2,070 (1) The “Valuation Adjustments” pertain to the restatement in relation to the misinterpretation of certain conversion terms of the CLN agreement and using the wrong output from the valuation report as described in Note 1 and Note 2. Six Months Ended June 30, 2021 (in thousands) As Reported Valuation Adjustments (1) As Restated Operating activities Net loss $ (136,258) $ 34,155 $ (102,103) Non-cash interest expense 2,245 — 2,245 Loss on issuance of convertible loans 44,242 9,725 53,967 Gain on disposal of property and equipment (4) — (4) Depreciation and amortization 2,155 — 2,155 Non-cash gain on foreign currency remeasurement (96) — (96) Loss on fair value of Advanced Subscription Agreements 6,765 (2,133) 4,632 Loss on fair value of derivative liability 56,616 (41,747) 14,869 Accounts receivable 79 — 79 Prepaid expenses and other current assets 2,795 — 2,795 Accounts Payable 2,547 — 2,547 Accrued expenses and other liabilities (358) — (358) Net cash used in operating activities (19,272) — (19,272) Investing Activities Purchase of property and equipment (251) — (251) Development of internal software (1,250) — (1,250) Net cash used in Investing Activities (1,501) — (1,501) Financing Activities Proceeds from issuance of convertible loans 16,222 16,222 Payment of issuance cost of convertible loans (1,004) (1,004) Net proceeds from issuance of long terms debt 17,265 — 17,265 Payment of issuance costs of long term debt (638) — (638) Repayment of other loan (84) — (84) Proceeds from issuance of related party debt 35 — 35 Repayment of related party debt (10,000) — (10,000) Payment of deferred financing costs (400) — (400) Net cash provided by financing activities 21,396 — 21,396 Effect of exchange rate changes on cash 231 — 231 Net increase in cash 854 — 854 Cash at the beginning of period 14,421 — 14,421 Cash at the end of the period $ 15,275 $ — $ 15,275 Supplemental Disclosure of non-cash Financing Activities Property and Equipment purchase in accounts payable $ 45 $ — $ 45 Deferred offering costs included in accounts payable and accrued expenses $ 5,404 $ — $ 5,404 Convertible notes issued through settlement of accounts payable and recognition of prepaid revenue share costs $ 4,832 $ 4,832 Supplemental Cash Flow information Interest paid $ 863 $ — $ 863 (1) The “Valuation Adjustments” pertain to the restatement previously disclosed in the Company's Original Form 10-K. Please see Note 1 and Note 2 for further details of the restatement. Nine Months Ended September 30, 2021 (in thousands) As Reported Valuation Adjustments (1) As Restated Operating activities Net loss $ (161,908) $ 38,934 $ (122,974) Non-cash interest expense 4,230 — 4,230 Loss on issuance of convertible loans 44,242 9,725 53,967 Gain on disposal of property and equipment (4) — (4) Depreciation and amortization 3,263 — 3,263 Non-cash loss on foreign currency remeasurement 527 — 527 Loss on fair value of Advanced Subscription Agreements 6,477 (2,007) 4,470 Loss on fair value of derivative liability 58,253 (46,652) 11,601 Changes in operating assets and liabilities — Accounts receivable (244) — (244) Prepaid expenses and other current assets 3,662 — 3,662 Accounts payable 5,171 — 5,171 Accrued expenses and other liabilities 6,404 — 6,404 Net cash used in operating activities (29,927) — (29,927) Investing activities Purchase of property and equipment (482) — (482) Development of internal software (2,136) — (2,136) Net cash used in investing activities (2,618) — (2,618) Financing activities Proceeds from issuance of convertible loans 16,222 16,222 Payment of issuance cost of convertible loans (1,004) (1,004) Net proceeds from issuance of long terms debt 25,631 — 25,631 Payment of issuance costs of long term debt (638) — (638) Repayment of other loan (84) — (84) Repayment of related party debt (10,143) — (10,143) Payment of deferred financing costs (3,148) — (3,148) Net cash provided by financing activities 26,836 — 26,836 Effect of exchange rate changes on cash (101) — (101) Net decrease in cash (5,810) — (5,810) Cash at the beginning of period 14,421 — 14,421 Cash at the end of the period $ 8,611 $ — $ 8,611 Supplemental disclosure of non-cash financing activities Property and equipment purchase in accounts payable $ 40 $ — $ 40 Advanced Subscription Agreements converted into ordinary shares $ 14,750 $ (1,993) $ 12,757 Deferred offering costs included in accounts payable and accrued expenses $ 5,392 $ — $ 5,392 Convertible notes issued through settlement of accounts payable and recognition of prepaid revenue share costs $ 4,714 $ 4,714 Supplemental cash flow information Interest paid $ 863 $ — $ 863 (1) The “Valuation Adjustments” pertain to the restatement previously disclosed in the Company's Original Form 10-K. Please see Note 1 and Note 2 for further details of the restatement. |
